Authors and Affiliates
Antonino Cassotta 1,2, Jérémie D Goldstein 1, Greta Durini 1, David Jarrossay 1, Franca Baggi Menozzi 3, Mario Venditti 4, Alessandro Russo 5, Marco Falcone 5, Antonio Lanzavecchia 1, Maria Cristina Gagliardi 6, Daniela Latorre 1,2, Federica Sallusto 1,2;
1 Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
2 Institute of Microbiology, ETH Zurich, Switzerland.
3 Servizio di Microbiologia EOLAB, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
4 Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
5 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
6 Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.
Authors and Affiliates
Hao H Yiu 1, Louis N Schoettle 2, Marlene Garcia-Neuer 2, Joseph N Blattman 2, Philip Lf Johnson 1;
1 Department of Biology, University of Maryland, College Park, MD, 20742, USA.
2 School of Life Sciences &, The Biodesign Institute, Arizona State University, Tempe, AZ, 85287, USA.
Authors and Affiliates
Zachary Sethna 1, Giulio Isacchini 2,3, Thomas Dupic 2, Thierry Mora 2, Aleksandra M Walczak 2, Yuval Elhanati 4;
1 Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
2 Laboratoire de physique de l'École Normale Supérieure, PSL University, CNRS, Sorbonne Université, Université de Paris 24 rue Lhomond, Paris, France.
3 Max Planck Institute for Dynamics and Self-organization, Am Faßberg 17, Göttingen, Germany.
4 Computational Oncology, Department of Epidemiology and Biostatistics, and Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
Authors and Affiliates
Joshua R Veatch 1, Naina Singhi 2, Brenda Jesernig 2, Kelly G Paulson 2, Jonathan Zalevsky 3, Ernesto Iaccucci 3, Scott S Tykodi 2,4, Stanley R Riddell 2;
1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA jveatch@fhcrc.org.
2 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
3 Nektar Therapeutics, San Francisco, California, USA.
4 Department of Medical Oncology, University of Washington, Seattle, Washington, USA.
Authors and Affiliates
Céline Lamacchia 1, Zuleika Calderin Sollet 2, Delphine Courvoisier 1, Denis Mongin 1, Gaby Palmer 1,3, Oliva Studer 1, Cem Gabay 1,3, Jean Villard 2, Stéphane Buhler 2, Axel Finckh 1;
1 Division of Rheumatology, Department of Internal Medicine Specialities.
2 Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals.
3 Department of Pathology-Immunology, University of Geneva School of Medicine, Geneva, Switzerland.
Authors and Affiliates
Yohei Sato 1, Laura Passerini 2, Brian D Piening 3, Molly Javier Uyeda 1,4, Marianne Goodwin 1, Silvia Gregori 2, Michael P Snyder 5, Alice Bertaina 1, Maria-Grazia Roncarolo 1,4,6, Rosa Bacchetta 1,6;
1 Department of Pediatrics Division of Hematology, Oncology Stem Cell Transplantation and Regenerative Medicine Stanford University School of Medicine Stanford CA USA.
2 Mechanisms of Peripheral Tolerance Unit San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) IRCCS San Raffaele Scientific Institute Milan Italy.
3 Earle A Chiles Research Institute Providence Portland Medical Center Portland OR USA.
4 Institute for Stem Cell Biology and Regenerative Medicine Stanford University School of Medicine Stanford CA USA.
5 Department of Genetics Stanford University School of Medicine Stanford CA USA.
6 Center for Definitive and Curative Medicine (CDCM) Stanford University School of Medicine Stanford CA USA.
Authors and Affiliates
Francesco R Simonetti 1, Hao Zhang 2, Garshasb P Soroosh 1, Jiayi Duan 1, Kyle Rhodehouse 1, Alison L Hill 3, Subul A Beg 1, Kevin McCormick 4, Hayley E Raymond 4, Christopher L Nobles 4, John K Everett 4, Kyungyoon J Kwon 1, Jennifer A White 1, Jun Lai 1, Joseph B Margolick 5, Rebecca Hoh 6, Steven G Deeks 6, Frederic D Bushman 4, Janet D Siliciano 1, Robert F Siliciano 1;
1 Department of Medicine, Johns Hopkins University, Baltimore, United States of America.
2 Department of Molecular Microbiology and immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States of America.
3 Department for Organismic and Evolutionary Biology, Harvard University, Cambridge, United States of America.
4 Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America.
5 Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltiomore, United States of America.
6 Division of HIV, Infectious Diseases, and Global Medicine, UCSF, San Francisco, United States of America.
Authors and Affiliates
Theresa A Proia 1, Maneesh Singh 1, Richard Woessner 2, Larissa Carnevalli 3, Gayathri Bommakanti 1, Lukasz Magiera 3, Srimathi Srinivasan 4, Shaun Grosskurth 5, Mike Collins 6, Chris Womack 7, Matthew Griffin 1, Minwei Ye 1, Susan Cantin 1, Deanna Russell 4, Mingchao Xie 4, Adina Hughes 3, Nanhua Deng 8, Deanna A Mele 1, Stephen Fawell 1, Simon Barry 3, Corinne Reimer 1, J Carl Barrett 4, Patricia McCoon 9;
1 Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.
2 Blueprint Medicines, Cambridge, Massachusetts.
3 Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
4 Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts.
5 AbbVie, Lake County, Illinois.
6 Tufts University Graduate School of Biomedical Sciences, Medford, Massachusetts.
7 Womack Consulting, Stamford, UK.
8 GSK, Cambridge, Massachusetts.
9 Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts. patricia.mccoon@astrazeneca.com.
Authors and Affiliates
Tiffany N Tanaka 1, Valentina Ferrari 2, Alison Tarke 2, Hannah Fields 2, Luca Ferrari 2, Franco Ferrari 1, Colin L McCarthy 1, Amber P Sanchez 3, Antonella Vitiello 2, Thomas A Lane 2, Rafael Bejar 4;
1 University of California San Diego Moores Cancer Center, La Jolla, California, USA.
2 PersImmune, Inc, San Diego, California, USA.
3 University of California San Diego Apheresis Program and Division of Nephrology, La Jolla, California, USA.
4 University of California San Diego Moores Cancer Center, La Jolla, California, USA. Electronic address: rabejar@health.ucsd.edu.
Authors and Affiliates
Akira Takagi 1, Masanori Matsui 2;
1 School of Medical Technology, Faculty of Health and Medical Care, Saitama Medical University, 1397-1 Yamane, Hidaka-city, Saitama 350-1241, Japan.
2 Department of Microbiology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama 350-0495, Japan mmatsui@saitama-med.ac.jp.
